Literature DB >> 6780596

Long term therapy with luteinizing hormone-releasing hormone in isolated gonadotropin deficiency: failure of therapeutic response.

D Rabin, L W McNeil.   

Abstract

We have evaluated the therapeutic response to exogenous LRH (1 mg, sc, either twice daily or three times daily) in six subjects with isolated gonadotropin deficiency. Four males were treated for 6 months, of whom two showed a transient rise in serum testosterone. However, testosterone levels subsequently remained at pretreatment levels in each of the four subjects during LRH therapy. One of the two female subjects displayed a transient rise in 17 beta-estradiol levels. All four males showed a notable rise in testosterone after hCG, and the one female tested responded to menotropins, while receiving LRH. We propose that the number of quanta of gonadotropins released per day with our therapeutic regimen was inadequate to generate a normal gonadal response.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6780596     DOI: 10.1210/jcem-52-3-557

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  2 in total

1.  Functions of the hypophysis-gonad and hypophysis-adrenal cortex systems during repeated administration of gonadotropin-releasing hormone in the postnatal period.

Authors:  N P Goncharov
Journal:  Neurosci Behav Physiol       Date:  1998 Sep-Oct

Review 2.  Luteinizing hormone-releasing hormone and its analogues: a review of biological properties and clinical uses.

Authors:  B J Furr; J R Woodburn
Journal:  J Endocrinol Invest       Date:  1988 Jul-Aug       Impact factor: 4.256

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.